Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: Observational study without post-test referral bias

European Heart Journal

Volumn 27, Issue 1, 2006, Pages 29-34

  Høilund Carlsen, Poul F ^a   Johansen, Allan ^a   Christensen, Henrik Wulff ^a   Vach, Werner ^b   Møldrup, Mette ^a   Bartram, Peter ^a   Veje, Annegrete ^a   Haghfelt, Torben ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Angina; Catheterization; Coronary disease; Observational study; Perfusion; Revascularization

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; EVALUATION; FEMALE; HEART CATHETERIZATION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SAMPLE SIZE; STABLE ANGINA PECTORIS;

ANGINA PECTORIS; CORONARY ANGIOGRAPHY; EXERCISE TEST; FEMALE; GATEKEEPING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PHYSICAL EXAMINATION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 28944439655     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi503     Document Type: Article

References (25)

1. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion scintigraphy in Europe - The EMPSRE study. Eur Heart J 1999;20:157-166.
2. Shaw LJ, Hachamovitch R, Berman DS, Marvick TH, Lauer MS, Heller GV, Iskandrian AE, Kesler KL, Travin MI, Lewin HC, Hendel RC, Borges-Neto S, Miller DD. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of pre-catherization ischaemia. Economics of Noninvasive Diagnosis (END) Study Group. J Am Coll Cardiol 1999;33:661-669.
3. Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, Berman DS, Miller DD. Cost analysis of diagnostic testing in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 1999;6:559-569.
4. Berman DS, Germano G, Shaw LJ. The role of nuclear cardiology in clinical decision making. Semin Nucl Med 1999;29:280-297.
5. Iskandrian AE. Viability assessment: clinical applications. In: Iskandrian AE, van der Wall EE, eds. Myocardial Viability. 2nd ed. Dordrecht: Kluwer Academic Publishers; 2000. p199-227.
6. Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O'Gara PT, Russell Jr RO, St. John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). 2003. American College of Cardiology Web Site. http://www.acc.org/clinical/guidelines/radio/index.pdf (11 March 2005).
7. Haghfelt T, Alstrup P, Grande P, Madsen JK, Rasmussen K, Thiis J. Guidelines for Diagnosis and Treatment of Angina Pectoris. Copenhagen: Danish Society of Cardiology and Danish Society of Thoracic Surgery, 1996.
8. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-575.
9. Campeau L. Letter: grading of angina pectoris. Circulation 1976;54:522-523.
10. Saunamäki K, Egstrup K, Mickley H, Nielsen JR, Schnohr P, Thomassen AR. Guidelines for Exercise-Testing in Ischemic Heart Disease. Copenhagen: Danish Society of Cardiology, 1995.
11. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J, Germano G. Separate acquisition rest thallium-201/stress technetium-99 m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-1464.
12. Johansen A, Høilund-Carlsen PF, Christensen HW, Grupe P, Veje A, Vach W, Haghfelt T. Observer variability in the evaluation of dual isotope Tl-201/Tc-99 m-sestamibi rest/stress myocardial perfusion SPECT in males and females with known or suspected stable angina pectoris. J Nucl Cardiol 2004;11:410-418.
13. Johansen A, Høilund-Carlsen PF, Christensen HW, Vach W, Jørgensen HB, Veje A, Haghfelt T. Diagnostic accuracy of myocardial perfusion scintigraphy in a study population without referral bias. J Nucl Cardiol, 2005;12:530-537.
14. Madsen JK, Bech J, Jørgensen E, Kastrup J, Kelbæk H, Saunamäki. Yield of 5,536 diagnostic coronary arteriographies: results from a data registry. Cardiology 2002;98:191-194.
15. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 Guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002. www.acc.org/clinical/guidelines/stable/stable.pdf (11 March 2005).
16. Hachamovitch R. Clinical value of combined perfusion and function imaging in the diagnosis, prognosis, and management of patients with suspected or known coronary artery disease. In: Germano G, Berman DS, eds. Clinical Gated Cardiac SPECT. Armonk, NY: Futura Publishing Company, Inc., 1999. p239-258.
17. Christensen HW, Vach W, Haghfelt T, Høilund-Carlsen PF. Observer reproducibility of cardiovascular classification systems for stable angina pectoris and cardiac functional status. (Abstract). J Nucl Cardiol 2003;10:S65.
18. Gobel FL, Stewart WJ, Campeau L, Hickey A, Herd JA, Forman S, White CW, Rosenberg Y. Safety of coronary arteriography in clinically stable patients following coronary bypass surgery. Post CABG Clinical Trial Investigators. Catheter Cardiovasc Diagn 1998;45:376-381.
19. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856-1864.
20. Krone RJ, Shaw RE, Klein LW, Block PC, Anderson HV, Weintraub WS, Brindis RG, McKay CR; ACC-National Cardiovascular Data Registry. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current 'stent era' of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol 2003;92:389-394.
21. Pell JP, Walsh D, Norrie J, Berg G, Colquhoun AD, Davidson K, Eteiba H, Faichney A, Flapan A, Hogg KJ, Jeffrey RR, Jennings K, McArthur J, Mankad P, Oldroyd K, Pell AC, Starkey IR. Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period. Heart 2001;85:662-666.
22. Johansen A, Høilund-Carlsen PF, Christensen HW, Vach V, Møldrup M, Haghfelt T. Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris. Eur J Nucl Med Mol Imaging, in press.
23. McDonald IG, Daly J, Jelinek VM, Panetta F, Gutman JM. Opening Pandora's box: the unpredictability of reassurance by a normal test result. BMJ 1996;313:329-332.
24. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, Berger PB, Shemin R, Attubato MJ, Williams DO, Frye R, Detre KM. Long-term clinical outcome in the Bypass Angioplasty Revascularisation Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation 2000;101:2795-2802.
25. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, Chamberlain DA; Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-1170.